Elon Musk's company Neuralink is testing a device that could help restore vision for babies born blind.
The aim of the study stands out as bringing brain-computer interface technology into the field of vision. The company's trial in this area is considered a new step attracting attention in the medical and technology worlds.
It is reported that human trials are expected to begin by the end of this year. This schedule indicates that the project may move from the experimental phase to the next stage.
This study conducted by Neuralink has brought the discussion of brain-based solutions for vision loss back to the agenda. Details on how the device will work are shared in a limited way.
With the start of human experiments, the safety, impact, and feasibility aspects of the project will become clearer. For now, the headline that stands out is that the company is working on a new device targeting vision.